Acadia Healthcare’s (ACHC) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a research note released on Friday morning,Benzinga reports. They currently have a $64.00 target price on the stock.

Several other research firms also recently commented on ACHC. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Price Performance

ACHC opened at $44.92 on Friday. Acadia Healthcare has a 1 year low of $36.50 and a 1 year high of $87.77. The stock has a 50-day moving average price of $40.48 and a 200-day moving average price of $58.19. The firm has a market cap of $4.17 billion, a PE ratio of 14.73, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the prior year, the company posted $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the period. Commonwealth Equity Services LLC raised its holdings in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares during the period. Atria Investments Inc boosted its stake in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after acquiring an additional 308 shares during the period. KBC Group NV grew its position in shares of Acadia Healthcare by 14.4% during the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after purchasing an additional 338 shares in the last quarter. Finally, Tidal Investments LLC raised its stake in Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after purchasing an additional 340 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.